Opioid use disorder: Difference between revisions
From IDWiki
No edit summary |
(→: fixed citation) |
||
Line 26: | Line 26: | ||
==Further Reading== |
==Further Reading== |
||
*Management of opioid use disorders: a national clinical practice guideline. ''CMAJ''. 2018;190(9):e247-e257. doi: [https://doi.org/10.1503/cmaj.170958 10.1503/cmaj.170958] |
|||
*[http://www.cmaj.ca/content/190/9/E247 Canadian Guidelines] |
|||
[[Category:Addiction medicine]] |
[[Category:Addiction medicine]] |
Revision as of 19:10, 9 July 2020
Background
- A substance use disorder involving heroin, fentanyl, or other opioid medications
Epidemiology
- The risk of OUD among patients treated with opioids for chronic pain is around 8 to 30%
Management
- Precipitated withdrawal more dangerous than natural withdrawal
Acute Overdose
- First give boluses of naloxone 0.04mg to 0.08mg IV to improve respiratory depression escalated quickly q2-3 minutes up to 0.4, 2, 4, 10, 15mg (start low and go fast)
- Then start infusion of 2/3 the effective dose per hour
- QRS and QT lengthening by blocking Na and K channels
- May need repeated defibrillation, overdrive pacing, or ECMO
Opioid Substitution Therapy (OST)
Further Reading
- Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):e247-e257. doi: 10.1503/cmaj.170958